Edition:
United States

Arena Pharmaceuticals Inc (ARNA.OQ)

ARNA.OQ on NASDAQ Stock Exchange Global Select Market

27.23USD
21 Nov 2017
Change (% chg)

$0.54 (+2.02%)
Prev Close
$26.69
Open
$26.77
Day's High
$27.43
Day's Low
$26.70
Volume
80,296
Avg. Vol
190,746
52-wk High
$28.90
52-wk Low
$11.30

Chart for

About

Arena Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing small molecule drugs across a range of therapeutic areas. The Company has three primary investigational clinical programs: etrasimod (APD334) in Phase II evaluation for ulcerative colitis, APD371 entering Phase II evaluation for the... (more)

Overall

Beta: 1.47
Market Cap(Mil.): $1,047.94
Shares Outstanding(Mil.): 39.26
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 200.64 15.49
EPS (TTM): -- -- --
ROI: -- -10.01 11.95
ROE: -- -35.77 15.94

BRIEF-Arena Pharmaceuticals reports Q3 loss per share $0.86

* Arena Pharmaceuticals provides corporate update and reports third quarter 2017 financial results

Nov 07 2017

BRIEF-Arena Pharmaceuticals Q2 loss per share $0.77

* Arena Pharmaceuticals provides corporate update and reports second quarter 2017 financial results

Aug 07 2017

BRIEF-Arena Pharmaceuticals says public offering of 6.25 mln common shares priced at $24 per share

* Arena Pharmaceuticals announces pricing of public offering of common stock

Jul 12 2017

BRIEF-Arena Pharmaceuticals announces proposed public offering of common stock

* Arena Pharmaceuticals announces proposed public offering of common stock

Jul 11 2017

Arena's heart-lung drug succeeds in mid-stage study, shares soar

U.S. drug developer Arena Pharmaceuticals Inc said on Monday its experimental drug for pulmonary arterial hypertension (PAH), a rare but deadly lung disease, met the main goal in a mid-stage study.

Jul 10 2017

BRIEF-Arena Pharmaceuticals Inc's board increased size of board from nine directors to ten directors

* Arena Pharmaceuticals Inc - on June 13, 2017, board of directors increased size of board from nine directors to ten directors Source text:(http://bit.ly/2rAYXbA) Further company coverage:

Jun 15 2017

BRIEF-Arena Pharmaceuticals says shareholders and board approve reverse stock split

* Arena Pharmaceuticals announces shareholders and board of directors approve reverse stock split

Jun 14 2017

Earnings vs. Estimates